Blood neuroexosomal excitatory amino acid transporter-2 is associated with cognitive decline in Parkinson’s disease with RBD

Blood neuroexosomal excitatory amino acid transporter-2 is associated with cognitive decline in Parkinson’s disease with RBD

BackgroundRapid eye movement (REM) sleep behavior disorder (RBD) predicts cognitive decline in Parkinson’s disease (PD) patients without dementia. However, underlying mechanisms remain unknown. Accumulating studies suggest glutamatergic system dysregulation is associated.ObjectiveTo examine the effe...

Full description

Bibliographic Details
Main Authors: Bing Leng, Hairong Sun, Mengfan Li, Junwu Zhao, Xiaoxiao Liu, Ran Yao, Tengqun Shen, Zhenguang Li, Jinbiao Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Aging Neuroscience
Subjects:
Parkinson’s disease
REM sleep behavior disorder
cognitive dysfunction
vesicular glutamate transporter-1
excitatory amino acid transporter-2
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2022.952368/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2022.952368/full

Similar Items